研究実績

Efficacy of SP and XP for HER2-negative unresectable advanced recurrent gastric cancer varies by histologic type

Hisato Kawakami, Kazuhiro Nishikawa, Toshio Shimokawa, Kazumasa Fujitani, Shigeyuki Tamura, Shunji Endo, Michiya Kobayashi, Junji Kawada, Yukinori Kurokawa, Akira Tsuburaya, Takaki Yoshikawa, Junichi Sakamoto, Taroh Satoh and on behalf of the HERBIS-2, HERBIS-4A and XParTS II Study Investigators

第20回日本臨床腫瘍学会学術集会 2023.3.16~18 福岡

前の記事 次の記事 一覧ページへ戻る